Trials / Completed
CompletedNCT05572749
Clinical Trial of Crocus Kozanis Administration in Obese Children and Adolescents
Double-blind Randomized Cross-over Clinical Trial of Crocus Kozanis Administration in Obese Children and Adolescents
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- All
- Age
- 10 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to investigate possible effects of per os Crocus Kozanis administration in children and adolescents with obesity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Crocus Kozanis | In this study, intervention will be the administration of Crocus Kozanis dietary supplement. Crocus Kozanis is a herb which is cultivated in Kozani, Greece. |
| DIETARY_SUPPLEMENT | Placebo of Crocus Kozanis | Placebo of Crocus Kozanis |
| DRUG | Metformin | Metformin will be administered in a dosage of 1000mg per day. Metformin is a formally approved therapy for children with diabetes in Europe. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2023-09-30
- Completion
- 2023-09-30
- First posted
- 2022-10-10
- Last updated
- 2024-02-08
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT05572749. Inclusion in this directory is not an endorsement.